ARCHIVES

The Antineoplaston Anomaly: How A Drug Was Used For Decades In Thousands Of Patients, With No Safety, Efficacy Data

This article is from The Cancer Letter archive.

Vol. 24 No. 36 | September 25, 1998

Download PDF Visit The Full Archive

Related Articles

Guest Editorial: The Supreme Court Decision on the ACA and What It Can Mean to Oncology

June 29, 2012

HIPAA Interpretations Vary, Delay Research, ASCO Study Finds

July 31, 2009

Prevention & Control Study Section In DRG Requested By NCI

February 8, 1991

Onco TCS Induces Responses In Relapsed Aggressive NHL

February 28, 2003

M.D. Anderson signs collaboration agreement with Institut Gustave Roussy.

February 13, 2004

Prostate Cancer Prevention Trial Begins At 222 U.S. Sites

October 22, 1993